Article info
Original article
Impact of the Council of Europe Resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients
- Correspondence to H P A Scheepers, Welfare and Sport, Health Care Inspectorate, Stadsplateau 1, Utrecht 3521 AZ, The Netherlands; hp.scheepers{at}igz.nl
Citation
Impact of the Council of Europe Resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients
Publication history
- Received June 10, 2016
- Revised July 26, 2016
- Accepted August 11, 2016
- First published September 5, 2016.
Online issue publication
June 29, 2017
Article Versions
- Previous version (5 September 2016).
- Previous version (27 March 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/